Tight glucose control in intensive care units: An update with an emphasis on nutritional issues

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 11, Issue 4, 2008, Pages 465-470

  Elia, Marinos ^a,b   De Silva, Aminda ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Critical illness; Glucose; Hypoglycaemia; Insulin; Mortality; Nutrition

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN; PHOSPHATE; POTASSIUM; ANTIDIABETIC AGENT;

BRAIN PERFUSION; CALORIC INTAKE; CARBOHYDRATE INTAKE; ENTERIC FEEDING; FEEDING BEHAVIOR; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE INTAKE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; HYPOVOLEMIA; INSULIN INFUSION; INSULIN TREATMENT; INTENSIVE CARE UNIT; NUTRITION; NUTRITIONAL ASSESSMENT; PARENTERAL NUTRITION; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; REVIEW; RISK FACTOR; SURVIVAL; CHEMICALLY INDUCED DISORDER; CRITICAL ILLNESS; INTENSIVE CARE; METABOLISM; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SURVIVAL;

EID: 54049088569     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e3282fcea2a     Document Type: Review

References (38)

1. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367.
2. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
3. Brunkhorst FM, Kuhnt E, Engel C, et al. Intensive insulin therapy in patients with severe sepsis and septic shock is associated with increased rate of hypoglycemia: results from a randomized multicenter study (VISEP). Infection 2005; 33 (Suppl 1):19.
4. Devos P, Preiser C, Melot C. Effects of intensive insulin therapy in critically ill patients on long-term outcome variables: data from the glucontrol study. Clin Nutr 2007; 2 (Suppl 2):5.
5. Farah R, Samokhvalov A, Zviebel F, Makhoul N. Insulin therapy of hypergly-cemia in intensive care. Isr Med Assoc J 2007; 9:140-142.
6. Arabi Y, Dabbagh O, Tamim H, et al. Intensive versus standard insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2006; 34 (Suppl):A65.
7. Bilotta F, Spinelli A, Giovannini F, et al. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neuro-intensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 2007; 19:156-160.
8. Beshnilian V. Clinical principles of occlusal rehabilitation. Rev Esp Parad 1968; 6:381-393.
9. http://www.thegeorgeinstitute.org/research/critical-care-&-trauma/ research/ normoglycaemia-in-intensive-care-evaluation-nice.cfm. [Accessed 19th December 2007].
10. Elia M, Livesey G. Energy expenditure and fuel selection in biological systems: the theory and practice of calculations based on indirect calorimetry and tracer methods. World Rev Nutr Diet 1992; 70:68-131.
11. Van den Berghe G, Wouters PJ, BouillonR, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366.
12. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55:3151-3159.
13. der Voort PH, Feenstra RA, Bakker AJ, et al. Intravenous glucose intake independently related to intensive care unit and hospital mortality: an argument for glucose toxicity in critically ill patients. Clin Endocrinol (Oxf) 2006; 64:141-145.
14. MarikPE, Varon J. Intensive insulin therapy in the ICU: is it now time to jump off the bandwagon? Resuscitation 2007; 74:191-193.
15. Devos P, Preiser J, Melot C. Incidence and risk factors fro hypoglycaemia in critically ill patients:data from the Glucontrol study. Clin Nutr 2007; 2 (Suppl 2):93-94.
16. Toft P, Jorgensen HS, Toennesen E, Christiansen C. Intensive insulin therapy to noncardiac ICU patients: a prospective study. Eur J Anaesthesiol 2006; 23:705-709.
17. VanhorebeekI, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007; 132:268-278.
18. Clayton SB, Mazur JE, Condren S, et al. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med 2006; 34:2974-2978.
19. Dan A, Jacques TC, O'Leary MJ. Enteral nutrition versus glucose-based or lipid-based parenteral nutrition and tight glycaemic control in critically ill patients. Crit Care Resusc 2006; 8:283-288.
20. Gandhi GY, Nuttall GA, Abel MD, et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 2007; 146:233-243.
21. Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006; 105:244-252.
22. Klein GW, Hojsak JM, Rapaport R. Hyperglycemia in the pediatric intensive care unit. Curr Opin Clin Nutr Metab Care 2007; 10:187-192.
23. Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev 2007; 23:184-192.
24. Pittas AG, Siegel RD, Lau J. Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2006; 30:164-172.
25. Diaz R, Goyal A, Mehta SR, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 2007; 298:2399-2405.
26. Mehta SR, YusufS, Diaz R, et al. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA 2005; 293:437-446.
27. Bohannon NJ. Large phosphate shifts with treatment for hyperglycemia. Arch Intern Med 1989; 149:1423-1425.
28. Marwick TH, Woodhouse SP. Severe hypophosphataemia induced by glucose-insulin-potassium therapy: a case report and proposal for altered protocol. Int J Cardiol 1988; 1 8:327-330.
29. Riley MS, Schade DS, Eaton RP. Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism 1979; 28:191-194.
30. Paula FJ, Plens AE, Foss MC. Effects of hypophosphatemia on glucose tolerance and insulin secretion. Horm Metab Res 1998; 30:281-284.
31. DeFronzo RA, Lang R. Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. N Engl J Med 1980; 303:1259-1263.
32. Heames RM, Cope RA. Hypophosphataemia causing profound cardiac failure after cardiac surgery. Anaesthesia 2006; 61:1211-1213.
33. Ogawa T, Kamikubo K. Hypokalemic periodic paralysis associated with hypophosphatemia in a patient with hyperinsulinemia. Am J Med Sci 1999; 318:69-72.
34. Quinn JA, Snyder SL, Berghoff JL, et al. A practical approach to hyperglycemia management in the intensive care unit: evaluation of an intensive insulin infusion protocol. Pharmacotherapy 2006; 26:1410-1420.
35. Juneja R, Roudebush C, Kumar N, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther 2007; 9:232-240.
36. Lonergan T, Le Compte A, Willacy M, et al. A simple insulin-nutrition protocol for tight glycemic control in critical illness: development and protocol comparison. Diabetes Technol Ther 2006; 8:191-206.
37. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139.
38. Home P. Safety of very tight blood glucose control in type 2 diabetes. BMJ 2008; 336:458-459.